Novo Nordisk, manufacturer of diabetes medications, has chosen Fluor Corporation to build its new Active Pharmaceutical Ingredient (API) facility in Clayton, North Carolina.
The new manufacturing facility will measure 830,000 square feet and provide approximately 700 new jobs when it is complete. At peak construction in mid-2018, the project will bring on board almost 2,500 craft employees and subcontractors. Irving, Texas-based Fluor said it anticipates that construction for the project will finish in mid-2019. Site prep is already in motion.
Juan G. Hernández, president of Fluor’s Life Sciences and Advanced Manufacturing business said “This project is the single largest life sciences facility investment in North Carolina’s history."
Fluor spokesman Brett Turner says the company will be hiring as many local contractors as it can to work on the project, "but at the end of the day, if we can't fill locally we have to fill them some way." Johnson County is gearing up to ensure there will be enough hotel rooms to accomodate construction crews with a new Hampton Inn & Suites in Benson and second hotel project in Smithfield.